These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36216843)

  • 1. Fecal microbiome alterations in treatment-naive de novo Parkinson's disease.
    Boertien JM; Murtomäki K; Pereira PAB; van der Zee S; Mertsalmi TH; Levo R; Nojonen T; Mäkinen E; Jaakkola E; Laine P; Paulin L; Pekkonen E; Kaasinen V; Auvinen P; Scheperjans F; van Laar T;
    NPJ Parkinsons Dis; 2022 Oct; 8(1):129. PubMed ID: 36216843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
    Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
    Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism.
    Barichella M; Severgnini M; Cilia R; Cassani E; Bolliri C; Caronni S; Ferri V; Cancello R; Ceccarani C; Faierman S; Pinelli G; De Bellis G; Zecca L; Cereda E; Consolandi C; Pezzoli G
    Mov Disord; 2019 Mar; 34(3):396-405. PubMed ID: 30576008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson's Disease: A Systematic Review.
    Boertien JM; Pereira PAB; Aho VTE; Scheperjans F
    J Parkinsons Dis; 2019; 9(s2):S297-S312. PubMed ID: 31498131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation.
    Romano S; Savva GM; Bedarf JR; Charles IG; Hildebrand F; Narbad A
    NPJ Parkinsons Dis; 2021 Mar; 7(1):27. PubMed ID: 33692356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Multi-Cohort Analysis of the Parkinson's Disease Gut Metagenome.
    Boktor JC; Sharon G; Verhagen Metman LA; Hall DA; Engen PA; Zreloff Z; Hakim DJ; Bostick JW; Ousey J; Lange D; Humphrey G; Ackermann G; Carlin M; Knight R; Keshavarzian A; Mazmanian SK
    Mov Disord; 2023 Mar; 38(3):399-409. PubMed ID: 36691982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Bacterial Gut Composition in Parkinson's Disease and Their Metabolic Contribution to Disease Development: A Gut Community Reconstruction Approach.
    Forero-Rodríguez J; Zimmermann J; Taubenheim J; Arias-Rodríguez N; Caicedo-Narvaez JD; Best L; Mendieta CV; López-Castiblanco J; Gómez-Muñoz LA; Gonzalez-Santos J; Arboleda H; Fernandez W; Kaleta C; Pinzón A
    Microorganisms; 2024 Feb; 12(2):. PubMed ID: 38399728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiota and Metabolome Alterations Associated with Parkinson's Disease.
    Vascellari S; Palmas V; Melis M; Pisanu S; Cusano R; Uva P; Perra D; Madau V; Sarchioto M; Oppo V; Simola N; Morelli M; Santoru ML; Atzori L; Melis M; Cossu G; Manzin A
    mSystems; 2020 Sep; 5(5):. PubMed ID: 32934117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of fecal short-chain fatty acids with clinical severity and gut microbiota in essential tremor and its difference from Parkinson's disease.
    Huang P; Zhang P; Du J; Gao C; Liu J; Tan Y; Chen S
    NPJ Parkinsons Dis; 2023 Jul; 9(1):115. PubMed ID: 37460569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Gut Microbiota Influence the Course of Parkinson's Disease? A 3-Year Prospective Exploratory Study in de novo Patients.
    Cilia R; Piatti M; Cereda E; Bolliri C; Caronni S; Ferri V; Cassani E; Bonvegna S; Ferrarese C; Zecchinelli AL; Barichella M; Pezzoli G
    J Parkinsons Dis; 2021; 11(1):159-170. PubMed ID: 33337387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates.
    Cosma-Grigorov A; Meixner H; Mrochen A; Wirtz S; Winkler J; Marxreiter F
    Front Neurol; 2020; 11():1041. PubMed ID: 33071933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson's disease.
    Li F; Wang P; Chen Z; Sui X; Xie X; Zhang J
    Neurosci Lett; 2019 Aug; 707():134297. PubMed ID: 31200089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Features of gut microbiota in patients with idiopathic Parkinson's disease].
    Li Y; Li RX; Du YT; Xu XJ; Xue Y; Gao D; Gao T; Sheng Z; Zhang LY; Tuo HZ
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):1017-1022. PubMed ID: 32294860
    [No Abstract]   [Full Text] [Related]  

  • 14. Gut microbiota in patients with Parkinson's disease in southern China.
    Lin A; Zheng W; He Y; Tang W; Wei X; He R; Huang W; Su Y; Huang Y; Zhou H; Xie H
    Parkinsonism Relat Disord; 2018 Aug; 53():82-88. PubMed ID: 29776865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson's Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder.
    Nishiwaki H; Hamaguchi T; Ito M; Ishida T; Maeda T; Kashihara K; Tsuboi Y; Ueyama J; Shimamura T; Mori H; Kurokawa K; Katsuno M; Hirayama M; Ohno K
    mSystems; 2020 Dec; 5(6):. PubMed ID: 33293403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
    Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
    J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
    Chen SJ; Chen CC; Liao HY; Lin YT; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
    Neurology; 2022 Feb; 98(8):e848-e858. PubMed ID: 34996879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson's disease patients for the identification and validation of biomarkers for Parkinson's disease subtypes, progression and pathophysiology.
    Boertien JM; van der Zee S; Chrysou A; Gerritsen MJJ; Jansonius NM; Spikman JM; van Laar T;
    BMC Neurol; 2020 Jun; 20(1):245. PubMed ID: 32534583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between Diet, the Gut Microbiome, and Short-Chain Fatty Acid Production among Older Caribbean Latino Adults.
    Maldonado-Contreras A; Noel SE; Ward DV; Velez M; Mangano KM
    J Acad Nutr Diet; 2020 Dec; 120(12):2047-2060.e6. PubMed ID: 32798072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of gut microbiota and metabolome with Parkinson's disease.
    Yan Z; Yang F; Cao J; Ding W; Yan S; Shi W; Wen S; Yao L
    Microb Pathog; 2021 Nov; 160():105187. PubMed ID: 34530073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.